Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

Name: Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
Published: 1995
License: Public Domain

National Center for Research Resources (NCRR) · 1995

ClinicalTrials.gov · Datasets · License: Public Domain · 1995

Open Source ↗

systemic-sclerosis

systemic sclerosis, raynaud disease, raynaud's syndrome, arthritis & connective tissue diseases, cardiovascular and respiratory diseases, rare disease, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

Related documents